The Peripheral Nerve Society is an international organization of physicians and scientists working together to develop and provide the best treatments for people who have peripheral nerve diseases. This goal is realized by cooperation - supporting research, training scientists and healthcare professionals, setting standards of care, creating new treatments, and facilitating clinical trials.

The Peripheral Nerve Society was founded in 1994, having evolved from two groups of academic investigators interested in understanding the basic biology and function of the peripheral nervous system - the nature of nerve injury and repair. These groups met periodically in closed meetings to discuss advances in this understanding and how this knowledge might be applied to care for patients with genetic, traumatic, toxic, or metabolic nerve disease. The interests of our members encompass all aspects of the peripheral nervous system, both clinical and scientific, and range from electrophysiologic tools for diagnosis to molecular mechanisms of disease and nerve fiber regeneration. The Society is incorporated, and open to general membership by those interested in the peripheral nervous system and its diseases.

DOWNLOAD application for PNS MEMBERSHIP. Complete the application form and fax to the Executive Secretary.

Inflammatory Neuropathy Consortium 
The INC is a Standing Committee of the PNS with scheduled meetings and specific goals for education, treatment and research of the inflammatory neuropathies. 
International Inflammatory Neuropathy Consortium

rsz_inc_2014_dusseldorf.jpg

ANNOUNCEMENT from the Peripheral Nerve Society

THE ALAN J. GEBHART – PERIPHERAL NERVE SOCIETY PRIZE FOR EXCELLENCE IN PERIPHERAL NERVE RESEARCH

The Board of the Peripheral Nerve Society is proud to announce that at the 2015 Meeting in Quebec City, Canada, the Alan J. Gebhart - Peripheral Nerve Society Prize for Excellence in Peripheral Nerve Research will be given for the first time. This Prize will be given to an established researcher in the field of peripheral nerve. The Awardee must be a member of the PNS in good standing for at least 2 (two) years. The amount of the Prize is US $50,000 to be used at the discretion of the Awardee.  The Board has created a Prize Committee who will select the winner. 

Applications (click here for application form) should include 1 complete set of the following materials: Completed application form, Current curriculum vitae with 10 papers most relevant to the Prize highlighted, and Letters from two colleagues either summarizing applicant's body of work including: relevant background material, research accomplishments placed in context and assessment of the direct or indirect impact of contributions to the understanding of PNS diseases Or describing the focus of the applicant's research program, the independent contributions made by the applicant in the field of peripheral nerve, and reasons why the applicant should receive the Prize. The application deadline is 1 March 2015.

The Prize will be presented at the Gala Dinner on Tuesday 30 June 2015 during the PNS 2015 meeting in Quebec City, Canada. The Awardee will give a 20 minute address during the meeting highlighting the research.

FUTURE MEETINGS OF THE PERIPHERAL NERVE SOCIETY

PNS 2015 Quebec City, Canada 27 June 2015 - 1 July 2015

INC 2016 University of Glasgow Scotland including the ‘GBS 100’ Centenary Symposium and Ceilidh 21-25 June 2016

 

GBS CIDP Foundation International

The GBS CIDP Foundation International is pleased to announce a competition for the first Benson Clinical Research Fellowship. The aim of the Fellowship to provide funds (up to $150k per year for three years) to enable clinicians or non­clinical scientists in training or having recently completed training to engage in a substantial research project in the field of inflammatory neuropathy at a center or centers of excellence. Preference will be given to candidates who intend to pursue a long-term career in this field.

Eventually 13 candidates, from Asia, Australia, Europe and the USA, submitted full applications. These have been considered by a 7 member Selection Committee who were hard pressed to select a short list of three candidates from an excellent field. The three chosen will present their proposals in public at the 13th International Symposium of the GBS CIDP Foundation International on the morning of Saturday November 1st at Disney's Coronado Springs Resort and Convention Center in Orlando, Fla. The audience will have the opportunity of voting in secret for the candidate they prefer. The Members of the Medical Advisory Board will have a separate vote. The Selection Committee will receive both sets of votes, interview the candidates and then recommend to the Foundation Board the most appropriate candidate for this prestigious award. The announcement of the successful candidate will be made later on the same day.

In alphabetical order, the short-listed candidates and their project titles are:

  • Dr Filip Eftimov, Amsterdam, The Netherlands: “Long-term outcome of CIDP treatment strategies”
  • Dr Ruth Huizinga, Rotterdam, The Netherlands: “High innate responsiveness to microbial triggers predisposing to the Guillain-Barré syndrome: identification of genetic causal variants”
  • Dr Rhona McGonigal, Glasgow, United Kingdom: “Identifying new therapeutic targets in mouse models of GBS”